Avenio in the News: Powering the Future of BioPharma AI
From major milestones to thought leadership, stay up to date with how we’re transforming clinical trials, compliance, and research intelligence.
August 5, 2025
Avenio.ai Appoints Dr. Megha Vasavada as VP of Product Management
Avenio.ai has appointed Dr. Megha Vasavada as VP of Product Management to lead product strategy for AvenioGPT, bringing over a decade of experience in clinical research to transform insight generation and decision-making across the clinical trial lifecycle.
FEATURED IN:
July 15, 2025
AvenioGPT Alpha Launch Sparks High Demand Across BioPharma
Avenio Corp launched AvenioGPT, an AI platform for life sciences and clinical research designed to reduce friction, enhance research velocity, and deliver actionable insight across BioPharma workflows, with early demand from 24 BioPharma entities and academic research institutes.
FEATURED IN:
May 21, 2024
Avenio Selected for NVIDIA Inception Program
Avenio joins NVIDIA Inception Program to scale Gen AI powered drug development process to revolutionize BioPharma research, reasoning, and coordination. The program provides access to NVIDIA's cutting-edge AI computing platform and resources to accelerate enterprise-grade BioPharma solutions.
FEATURED IN: